Gelteq Limited Ordinary Shares Stock (NASDAQ:GELS)
Previous Close
$2.77
52W Range
$1.42 - $5.50
50D Avg
$2.42
200D Avg
$2.43
Market Cap
$25.95M
Avg Vol (3M)
$515.51K
Beta
-
Div Yield
-
GELS Company Profile
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.